Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
about
Management of people with intermediate-stage hepatocellular carcinoma: a network meta-analysisTowards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examplesCurrent Treatment Approaches to HCC with a Special Consideration to TransplantationNonalcoholic Lipid Accumulation and Hepatocyte Malignant TransformationUtilization of animal models to investigate non-alcoholic steatohepatitis-associated hepatocellular carcinomaCirculating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular CarcinomaIs Liver Enzyme Release Really Associated with Cell Necrosis Induced by Oxidant Stress?Risk Factors for the Development of Hepatocellular Carcinoma in ThailandContribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinomaPathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathwaysImmunology of hepatocellular carcinomaAdvances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinomaDPP4 in DiabetesBiological features and biomarkers in hepatocellular carcinomaMitochondrial fatty acid oxidation in obesityAEG-1/MTDH/LYRIC in liver cancerOmega-3 fatty acids for the treatment of non-alcoholic fatty liver diseaseLessons from mouse models of high-fat diet-induced NAFLDExposure to ambient air particulate matter and non-alcoholic fatty liver diseaseObesity and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese populationFunctional roles of protein nitration in acute and chronic liver diseasesRole of microRNAs in hepatocellular carcinoma: a clinical perspectiveThe stress-regulated transcription factor CHOP promotes hepatic inflammatory gene expression, fibrosis, and oncogenesisHepatocellular carcinoma in patients with non-alcoholic fatty liver diseaseHepatocellular carcinoma in nonalcoholic fatty liver disease mimicking benign hemangioma: two case reports and literature reviewImmune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic TargetsNASH Cirrhosis - the New Burden in Liver Transplantation: How Should It Be Managed?Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse modelPrevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challengesObesity and non-alcoholic fatty liver disease: Disparate associations among Asian populationsNotch activation drives adipocyte dedifferentiation and tumorigenic transformation in miceThe potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinomaEnvironmental pollution: a tangible risk for NAFLD pathogenesisNon-alcoholic Fatty Liver Disease in South Asians: A Review of the LiteratureHepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management.Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine.Cost-utility analysis of nonalcoholic steatohepatitis screening.Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation.Obesity, adipokines and hepatocellular carcinoma.MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.
P2860
Q24186892-FB637C51-0587-4160-98B5-77CBDE9380D1Q24289511-26D1A4E0-B42A-4B15-A98A-1655CC235E81Q26740375-AF6141B2-9D74-436C-9CE9-EFDA7160172AQ26746521-2A473573-A537-4933-9455-A9679DCB71EBQ26748807-ADF19397-473C-48B3-89B2-4160D7A6A699Q26767346-0E61FC1F-C7C2-488F-9D6E-6F36A7FCBB3CQ26769973-F8472B08-9716-46F4-B7D3-F75872ED5AA0Q26775650-DB71532E-ECCA-4B07-87CE-434250E31119Q26781477-4BBD5968-D164-4AB1-9B2F-DE269FFB932FQ26783372-049F73F3-671B-48A5-B6D3-8267CBB9B44DQ26795411-B8EBE3EB-AFEB-4AF7-A8DB-6756DE22A252Q26795529-2C433742-3997-4770-927A-03C1332706FAQ26797335-03D4378F-77B8-4A8F-BEC5-B69AC8B7BF70Q26799462-A679EF4B-1668-4183-BE29-0D381BC26788Q26820838-97A61323-E21E-4818-B725-EF19809B9F9FQ26822570-850BA2E1-1974-4CEA-9B91-ACF5D59B185AQ26825517-5AB6AB8C-3F85-46B9-ABBB-661C6BDB3891Q26829532-FEA59A12-8DC4-4C43-8832-88DE34E458F8Q26997401-33050195-D60E-44F3-99CA-971B155A78C9Q27003363-890659C3-6873-4E7B-B2E3-B96BBCCB9812Q27008888-0999CEE2-1DFB-4851-998B-C2414B06E351Q27014034-1EAA8A6B-5016-4CA2-960B-B95CFA313585Q27319729-8D0AAD55-CD6D-4DA6-A14A-887274A1D420Q28066100-9864F9D4-532D-4DE2-A673-72A26A632282Q28077023-18FF2AE2-3EE5-42DF-A974-4E68E0268157Q28079713-5AA5BEC2-E34A-4824-84F2-002BE66AE2E5Q28079900-4FB015C7-4F51-41E9-95FE-CCE23D61E63EQ28268632-204E6F60-6331-4B27-9EE4-B59FFDE69A3CQ28272678-6C5C4232-DB3F-41BA-83D9-F0F1383EC2C4Q28386598-2DC96573-36E1-459C-8901-E16B7D2E422AQ28389770-9F03297E-3385-4F8F-BAB0-0E2BD255372DQ28392224-91490614-17CE-45EE-82AF-DF3FF578489BQ28661241-8339364A-A6F7-4996-9EAC-6E00F8161EB2Q30234443-CC62A323-BC0E-4AF0-A986-E255D3CDF505Q30234574-65B671F1-DE5C-4F1E-A52B-995F838EB232Q30301218-DCE31732-564E-4BFD-A3CC-6EF933A81924Q30385602-6429C98F-B3EE-4B5F-B6ED-49C9539E8721Q30402324-A71913C1-BC67-4D1E-B335-05501F04186DQ30427127-6AD88843-205A-44B5-905E-C9BB587E9068Q30439971-3CEF45E4-7636-430E-87FF-4D9F729EACC9
P2860
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
@en
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
@nl
type
label
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
@en
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
@nl
prefLabel
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
@en
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
@nl
P2093
P356
P1433
P1476
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
@en
P2093
Brad Q Starley
Christopher J Calcagno
Stephen A Harrison
P304
P356
10.1002/HEP.23594
P407
P577
2010-05-01T00:00:00Z